Periodic Reporting for period 2 - Prevent-nCoV (Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine)

The Prevent-nCoV consortium has during the project period generated pre-clinical proof of concept as well as cGMP manufacture, toxicological studies for capsid virus like particle (cVLP) delivery of SARS-CoV-2 antigens, as well as concluded a first-in-human clinical trial. The...